Securities code: 688013 securities abbreviation: Touchstone International Medical Science Co.Ltd(688013) Announcement No.: 2022-001
Touchstone International Medical Science Co.Ltd(688013)
Suggestive announcement on the reduction of more than 1% by shareholders holding more than 5%
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. Important content tips:
This equity change belongs to the reduction of shareholders’ holdings and does not touch the tender offer.
After this equity change, the number of Touchstone International Medical Science Co.Ltd(688013) (hereinafter referred to as “the company” or ” Touchstone International Medical Science Co.Ltd(688013) “) shares held by the information disclosure obligor inspire surgical Limited (hereinafter referred to as “Yingjie medical”) decreased from 7792260 shares to 6192260 shares, and the proportion of shares held in the total share capital of the company decreased from 9.7403% to 7.7403%.
This equity change is the reduction of more than 5% of the shares held by non largest shareholders, which is carried out through block trading, and will not change the controlling shareholder and actual controller of the company.
The transferee of this block transaction shall not transfer the transferred shares within 6 months after the transfer.
On December 31, 2021, the company received the notification letter on the results of share reduction issued by Yingjie medical, the shareholder of the company, and now informs the relevant changes in equity as follows:
1、 Basic information of this equity change
In this equity change, Yingjie medical, the information disclosure obligor, reduced 1600000 shares of the company’s non tradable shares through block transactions, accounting for 2% of the total share capital of Touchstone International Medical Science Co.Ltd(688013) . The specific changes are as follows:
Information Name: inspire surgical Limited
Address: room 1702, business center, 108 Java Road, North Point, Hong Kong
When the basic rights and interests of the owner change
Information room December 31, 2021
Change method change date stock type reduction quantity reduction proportion
Equity conversion (share)
Detailed block trading of A-Shares 16000002.0000% on December 31, 2021
Total 16000002.0000%
remarks:
1. All the shares involved in this equity change enjoy voting rights, and there are no restrictions on the transfer of voting rights, such as delegation or restriction of voting rights.
2. This change does not violate the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies and other laws and regulations, the business rules of Shanghai Stock Exchange and other relevant provisions and relevant commitments.
2、 Before and after this equity change, information disclosure obligors own shares of the company’s equity
Share capital held before the change and shares held after the change name of shareholders nature of shares
Number of shares in total number of shares (shares) in total share capital
Yingjie Medical Co., Ltd. holds 77922609.7403% shares and 61922607.7403% shares
(inspire surgical, where: none)
Conditions for restricted sale 77922609.7403% 61922607.7403% Limited) tradable shares
share
Note: after this equity change, all shares held by the information disclosure obligor enjoy voting rights, and there are no restrictions on the transfer of voting rights or restrictions such as delegation or restriction of voting rights.
3、 Description of other relevant matters
1. This equity change is a reduction, which does not involve the tender offer and the source of funds.
2. The change in equity is the reduction of the non largest shareholder holding more than 5%, which will not lead to the change of the controlling shareholder and actual controller of the company, and will not have a significant impact on the corporate governance structure and sustainable operation.
3. According to the provisions of laws, regulations and normative documents such as the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – equity change report, this equity change does not involve the disclosure of equity change report by the information disclosure obligor.
It is hereby announced.
Touchstone International Medical Science Co.Ltd(688013) board of directors January 4, 2022
